Clinical Trial: A Dose-finding Study of Silodosin in Patients With Urinary Calculi
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomized, Double-blind, Placebo-controlled, Phase II Study of Silodosin in Patients With Urinary Calculi
Brief Summary: The purpose of this study is to evaluate the efficacy and the safety of silodosin in urinary calculi patients.
Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.
Current Primary Outcome: Spontaneous stone passage rate [ Time Frame: 4 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Time to spontaneous stone passage [ Time Frame: 4 weeks ]
- Analgesic use [ Time Frame: 4 weeks ]
- Pain severity [ Time Frame: 4 weeks ]
Original Secondary Outcome: Same as current
Information By: Kissei Pharmaceutical Co., Ltd.
Dates:
Date Received: February 21, 2012
Date Started:
Date Completion:
Last Updated: October 29, 2013
Last Verified: October 2013